The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of Patients who Complete Qualitative Measure - Perceived Usefulness
Timeframe: Day 1 (60 minutes)
Percentage of Patients who Complete Qualitative Measure - Perceived Usability
Timeframe: Day 1 (60 minutes)
Percentage of Patients who Complete Qualitative Measure - Perceived Use Challenges
Timeframe: Day 1 (60 minutes)
Percentage of Patients who Complete Qualitative Measure - Perceived Value
Timeframe: Day 1 (60 minutes)